We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,688 results
  1. A case-control study on the risk factors associated with the occurrence of non-tuberculous mycobacteria pulmonary disease in bronchiectasis patients

    Objective

    The objective of this study is to analyze the risk factors associated with bronchiectasis combined with non-tuberculous mycobacteria...

    Yin** Feng, **g Guo, ... Zun**g Zhang in BMC Pulmonary Medicine
    Article Open access 20 November 2023
  2. Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis

    Introduction

    Over the last ten years an increasing prevalence and incidence of non-tuberculous mycobacteria (NTM) has been reported among patients...

    Andrea Gramegna, Sofia Misuraca, ... Francesco Blasi in Respiratory Research
    Article Open access 16 December 2023
  3. Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon—a cross-sectional study

    Background

    Non-tuberculous mycobacteria (NTM) are a group of bacteria that cause rare lung infections and are increasingly recognized as causative...

    Micheska Epola Dibamba Ndanga, Jabar Babatundé Pacome Achimi Agbo Abdul, ... Ayola Akim Adegnika in BMC Infectious Diseases
    Article Open access 03 October 2023
  4. Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity?

    Immune checkpoint inhibitors (ICIs) are drugs growingly employed in cancer immunotherapy which have significantly improved the prognosis of several...

    Cecilia Azzarà, Andrea Lombardi, ... Alessandra Bandera in BMC Infectious Diseases
    Article Open access 04 September 2023
  5. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis

    Non-tuberculous mycobacteria (NTM) are an emerging group of pulmonary infectious pathogens of increasing importance to the management of patients...

    Andrew Burke, Daniel Smith, ... Jason A. Roberts in Clinical Pharmacokinetics
    Article 13 May 2021
  6. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

    Background

    Non-tuberculous mycobacteria (NTM) are generally free-living organism, widely distributed in the environment, with sporadic potential to...

    A. Calcagno, N. Coppola, ... D. Goletti in Infection
    Article Open access 08 February 2024
  7. Thoracic empyema due to nontuberculous mycobacteria in an immunocompetent patient without pulmonary disease: a case report

    Background

    Pleural involvement by non-tuberculous mycobacteria (NTM), especially NTM empyema in the immunocompetent patient without pulmonary diseases...

    Fengjiao Yu, Yongxia Li, ... Yu Jiang in BMC Pulmonary Medicine
    Article Open access 19 June 2023
  8. Comparison of treatment modalities for non-tuberculous mycobacterial cervicofacial lymphadenitis in children

    Purpose

    We aim to compare the different treatment modalities of non-tuberculous cervicofacial lymphadenitis in children, by means of a retrospective...

    T. Mennes, V. Vander Poorten, ... G. Hens in European Archives of Oto-Rhino-Laryngology
    Article 12 December 2023
  9. The additional value of 18F-FDG PET/CT imaging in guiding the treatment strategy of non-tuberculous mycobacterial patients

    Objectives

    Non-tuberculous mycobacteria (NTM) infection is an increasing health problem due to delaying an effective treatment. However, there are few...

    Donghe Chen, Yunbo Chen, ... **nhui Su in Respiratory Research
    Article Open access 18 March 2024
  10. The successful treatment of microscopic polyangiitis associated with non-tuberculous mycobacterial-pulmonary disease

    While the incidence and prevalence of non-tuberculous mycobacterial-pulmonary disease (NTM-PD) are increasing and microscopic polyangiitis (MPA) is...

    Ryuichi Yoshii, Kengo Kajiwara, ... Masashi Mukoyama in CEN Case Reports
    Article 09 December 2023
  11. Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan

    Background

    There is scarce knowledge on the prevalence of diseases caused by non-tuberculous mycobacteria (NTM) in Pakistan. In the absence of culture...

    Asifa Karamat, Atiqa Ambreen, ... Tehmina Mustafa in BMC Infectious Diseases
    Article Open access 24 April 2021
  12. Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report

    Background

    Mycobacterium obuense (M. obuense ) is a rapidly growing mycobacterium (RGM) which has been considered nonpathogenic. Here, we report a...

    Maiko Naito, Kentaro Fukushima, ... Atsushi Kumanogoh in BMC Infectious Diseases
    Article Open access 08 August 2023
  13. Surgical site infections by atypical mycobacteria: prevalence and species characterization using MALDI-TOF and molecular LCD chip array

    Background

    Surgical site infection (SSI) is a post-operative complication of high concern with adverse impact on patient prognosis and public health...

    Maha A. Gad, Sahar M. Khairat, ... Noha S. Soliman in Infection
    Article Open access 18 June 2022
  14. Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice

    Objective

    To compare non-tuberculous mycobacterial pulmonary disease (NTMPD) diagnosis by metagenomic next-generation sequencing (mNGS) with Bactec...

    Wei Wei, Jie Cao, ... Qin Sun in Infection
    Article Open access 01 August 2022
  15. The value of multimodal ultrasonography in differential diagnosis of tuberculous and non-tuberculous superficial lymphadenitis

    Background

    To investigate the value of multimodal ultrasonography in differentiating tuberculosis from other lymphadenopathy.

    Methods

    Sixty...

    Jie Chu, Ying Zhang, ... Gaoyi Yang in BMC Surgery
    Article Open access 14 December 2021
  16. Radiologic Characteristics of Non-tuberculous Mycobacteria Infection in Patients with Bronchiectasis

    Introduction

    Non-tuberculous mycobacteria pulmonary disease (NTM-pd) commonly complicates bronchiectasis. However, clinical and radiological features...

    Iya Eisenberg, Alaa Yasin, ... Michal Shteinberg in Lung
    Article 26 June 2020
  17. Extracellular vesicles from serum samples of mycobacteria patients induced cell death of THP-1 monocyte and PBMC

    Background

    Extracellular vesicles (EVs) play a key role in cell communication and the pathogenesis of some diseases. EVs may accelerate cell death...

    Alireza Javadi, Masoud Shamaei, ... Bahram Kazemi in BMC Pulmonary Medicine
    Article Open access 09 February 2022
  18. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study

    Background

    The objective of the study was to describe the epidemiology, management and cost of non-tuberculous mycobacteria pulmonary disease (NTM-PD)...

    Nicolas Veziris, Claire Andréjak, ... Raphaël Chiron in BMC Infectious Diseases
    Article Open access 17 November 2021
  19. Mycobacterium Wolinskyi: A New Non-Tuberculous Mycobacterium Associated with Cardiovascular Infections?

    Mycobacterium wolinskyi is a rapid-growth non-tuberculous mycobacterium. Twenty-one cases of M. wolinskyi infection have been described so far, more...

    Marta Hernández-Meneses, Julian González-Martin, ... Jaime Llopis in Infectious Diseases and Therapy
    Article Open access 15 March 2021
Did you find what you were looking for? Share feedback.